期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
荧光标记MOMP抗体检测沙眼衣原体的方法及性能评价 被引量:3
1
作者 刘小平 樊尚荣 +2 位作者 陈晓明 黄荣 闫津津 《标记免疫分析与临床》 CAS 2019年第5期858-862,共5页
目的建立异硫氰酸荧光素标记沙眼衣原体主要外膜蛋白单克隆抗体直接免疫荧光法检测沙眼衣原体的方法,并评价其灵敏度和特异性。方法双盲法。采集女性宫颈拭子双份,一份免疫荧光法检测,另一份采用荧光定量PCR检测。以PCR测定结果作为标准... 目的建立异硫氰酸荧光素标记沙眼衣原体主要外膜蛋白单克隆抗体直接免疫荧光法检测沙眼衣原体的方法,并评价其灵敏度和特异性。方法双盲法。采集女性宫颈拭子双份,一份免疫荧光法检测,另一份采用荧光定量PCR检测。以PCR测定结果作为标准,分别计算DFA和PCR结果的一致性。结果共检测142份宫颈拭子,准确率为99.3%,其中阳性符合率为90.9%,阴性符合率为100%。Kappa系数一致性检验,k为0.894。荧光标记MOMP抗体检测沙眼衣原体灵敏度、特异性与PCR两种方法检测结果一致。结论异硫氰酸标记沙眼衣原体主要外膜蛋白单克隆抗体法检测沙眼衣原体有较高的灵敏度和特异性,可用于临床检验。 展开更多
关键词 沙眼衣原体 主要外膜蛋白单克隆抗体 异硫氰酸荧光素
下载PDF
酮康唑栓治疗重度外阴阴道假丝酵母菌病有效性研究 被引量:1
2
作者 米兰 张岱 +7 位作者 樊尚荣 薛敏 薛凤霞 安瑞芳 张蕾 王威 王悦 孙宇辉 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2024年第3期340-343,共4页
目的 评价酮康唑栓治疗重度外阴阴道假丝酵母菌病的有效性、不良反应及复发率。方法 2022年4月至2023年10月由9家医院共同开展,以阴道分泌物真菌培养和临床症状及体征评分确诊为重度外阴阴道假丝酵母菌病的患者为观察对象,采用前瞻性随... 目的 评价酮康唑栓治疗重度外阴阴道假丝酵母菌病的有效性、不良反应及复发率。方法 2022年4月至2023年10月由9家医院共同开展,以阴道分泌物真菌培养和临床症状及体征评分确诊为重度外阴阴道假丝酵母菌病的患者为观察对象,采用前瞻性随机、阳性药物平行对照的多中心临床研究设计,共纳入253例患者,按照1∶1比例以随机数字表法分配至研究组与对照组:研究组136例使用酮康唑栓每晚400mg阴道给药,连用6d;对照组117例使用硝酸咪康唑阴道软胶囊400mg阴道给药,连用6d。分别在停药后10d及30d进行2次随访,评价药物治疗效果;以症状及体征评分下降≥67%为临床痊愈,临床痊愈且真菌学阴性的患者占比为临床总有效率(主要疗效指标),同时记录患者的不良反应。结果 停药后10d随访时,临床总有效率研究组和对照组分别为84.6%、78.6%;真菌学痊愈率研究组为87.5%、对照组为83.8%;临床痊愈率研究组为91.2%、对照组为88.0%,上述指标两组差异均无统计学意义。停药后30d临床痊愈率研究组为91.9%、对照组为81.1%,差异无统计学意义;真菌学复发率研究组为14.8%,对照组为26.7%,差异有统计学意义(P=0.039)。不良反应主要包括阴道刺激、瘙痒和灼热感,研究组不良反应发生率低于对照组(P<0.001)。结论 在重度外阴阴道假丝酵母菌病的治疗方面,酮康唑栓的临床疗效及真菌学疗效不劣于硝酸咪康唑阴道软胶囊,酮康唑栓的复发率及不良反应发生率低于硝酸咪康唑阴道软胶囊。 展开更多
关键词 酮康唑 重度外阴阴道假丝酵母菌病 治疗
原文传递
复方芙蓉泡腾栓治疗细菌性阴道病合并需氧菌性阴道炎的随机、阳性药平行对照、多中心临床非劣效研究 被引量:2
3
作者 刘瑛 张琼琼 +28 位作者 李萌 易红英 宋殿荣 娄英 樊尚荣 杨兴升 路静 胡丽娜 周萍 安瑞芳 韩凤娟 罗喜平 高珊 宋维花 薛凤霞 杨永秀 殷昭君 王稳莹 张蓓 李萍 孙宇辉 乔峤 郝敏 张岱 刘朝晖 吕涛 张蕾 魏绍斌 廖秦平 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2023年第10期1017-1023,共7页
目的 以克林霉素磷酸酯阴道用乳膏为阳性对照,通过随机、阳性药平行对照、多中心的临床研究,评价复方芙蓉泡腾栓治疗细菌性阴道病(bacterial vaginosis,BV)合并需氧菌性阴道炎(aerobic vaginitis,AV)的临床有效性及安全性。方法 于2019... 目的 以克林霉素磷酸酯阴道用乳膏为阳性对照,通过随机、阳性药平行对照、多中心的临床研究,评价复方芙蓉泡腾栓治疗细菌性阴道病(bacterial vaginosis,BV)合并需氧菌性阴道炎(aerobic vaginitis,AV)的临床有效性及安全性。方法 于2019年12月至2021年7月,在全国26家三甲医院纳入600例经阴道微生态检查和中医临床证候评分,确诊为BV合并AV的患者,按随机数字表法1∶1比例分为研究组(复方芙蓉泡腾栓2.2 g组)和对照组(2%克林霉素磷酸酯阴道用乳膏5 g组),两组患者均每晚阴道上药1次,连续12 d。记录停药后3~5 d和停药后(28±3)d药物的治疗效果(治愈率、BV有效率、AV有效率、疾病复发率、乳杆菌分级变化等)及不良反应发生情况,用中医临床证候评分的差值评价临床症状改善情况。非劣效检验的非劣效界值设为12%。结果 最终符合方案集的患者共559例(研究组285例,对照组274例)。在停药后3~5 d随访时,研究组和对照组BV合并AV的治愈率分别为63.5%(181/285)和67.2%(184/274),BV有效率分别为79.3%(226/285)和84.7%(232/274),AV有效率分别为71.2%(203/285)和74.1%(203/274),三者率差的95%置信区间的置信下限均大于-12%,表明研究组的治愈率、BV有效率和AV有效率均不劣于对照组。研究组中医证候总有效率、中医单项症状消失率(带下量多、色黄有味、阴部瘙痒、阴中灼热、脘闷纳呆、口苦口腻、大便黏滞)、乳杆菌分级变化均不劣于对照组。停药后(28±3)d随访时,研究组和对照组AV合并BV的复发率分别为13.8%(25/181)和8.7%(16/184),该率差的95%置信区间的置信上限小于12%,表明研究组非劣于对照组。随访期间两组不良反应发生率[主要包括继发外阴阴道假丝酵母菌病(VVC)、瘙痒、灼热感和疼痛等]差异无统计学意义(P>0.05)。结论在BV合并AV的治疗上,复方芙蓉泡腾栓在治愈率、乳杆菌分级变化、临床症状改善以及不良反应方面不劣于克林霉素磷酸酯阴道用乳膏。 展开更多
关键词 复方芙蓉泡腾栓 克林霉素磷酸酯阴道用乳膏 细菌性阴道病 需氧菌性阴道炎 非劣效研究
原文传递
New Concept and Management for Sepsis in Pregnancy and the Puerperium 被引量:2
4
作者 fan shang-rong Liu Ping +2 位作者 Yan Shao-Mei Huang Lei Liu Xiao-Ping 《Maternal-Fetal Medicine》 2020年第4期231-239,共9页
Sepsis,which is life-threatening organ dysfunction resulting from a dysregulated host response to infection,remains a major cause for the admission of pregnant women to the intensive care unit and is one of the leadin... Sepsis,which is life-threatening organ dysfunction resulting from a dysregulated host response to infection,remains a major cause for the admission of pregnant women to the intensive care unit and is one of the leading causes of maternal morbidity and mortality.The obstetric causes include uterine infection,septic abortion,and wound infection.The non-obstetric causes include pyelonephritis and pneumonia.Maternal sepsis may also be from obstetrical critical illness,such as obstetric severe hemorrhage,obstetric(amniotic fluid/pulmonary)embolism,acute fatty liver of pregnancy,and congestive heart failure,cardiopulmonary arrest,and major trauma.The most commonly reported pathogens in maternal sepsis include Escherichia coli,Streptococcus,Staphylococcus,and other gram-negative bacteria.Maternal sepsis may cause intrauterine infection,which results in(1)preterm premature rupture of membranes or preterm labor or birth,(2)cerebral white matter damage or cerebral palsy or neurodevelopmental delay,(3)stillbirth,(4)early-or late-onset sepsis,and(5)perinatal death.The"Hour-1 bundle"should be initiated within the first hour of the recognition of sepsis.The use of early,appropriate antibiotics is crucial in the management of maternal sepsis.Fetal status should be monitored.Appropriate and early source control should be provided.The decision for delivery is often quite complex and should be individualized to each patient’s clinical scenario while taking into consideration the suspected source of infection,maternal status,fetal well-being,and gestational age.Extracorporeal membrane oxygenation has been increasingly used in refractory sepsis during pregnancy and the puerperium. 展开更多
关键词 SEPSIS PREGNANCY PUERPERIUM MATERNAL Fetal MORBIDITY Mortality Maternal near-miss
原文传递
Diagnosis and Management of Intraamniotic Infection 被引量:2
5
作者 fan shang-rong Liu Ping +2 位作者 Yan Shao-Mei Peng Ji-Ying Liu Xiao-Ping 《Maternal-Fetal Medicine》 2020年第4期223-230,共8页
Intraamniotic infection(IAI)or chorioamnionitis is a common cause of preterm birth and may cause adverse neonatal outcomes,including neonatal pneumonia,respiratory distress,meningitis,sepsis,and death.Maternal morbidi... Intraamniotic infection(IAI)or chorioamnionitis is a common cause of preterm birth and may cause adverse neonatal outcomes,including neonatal pneumonia,respiratory distress,meningitis,sepsis,and death.Maternal morbidities from intraamniotic infection include dysfunctional labor requiring increased intervention,cesarean birth,postpartum uterine atony with hemorrhage,endometritis,peritonitis,sepsis,adult respiratory distress syndrome and,rarely,death.Chorioamnionitis can result from an ascending infection,iatrogenic causes or transplacental passage from maternal blood-borne infections.The clinical findings of chorioamnionitis include maternal fever(≥38°C),maternal(>100 beats per minute)and/or fetal tachycardia(>160 beats per minute),maternal leukocytosis on complete blood count(>15000 cells/mm 3),and uterine tenderness and/or purulent and/or foul-smelling amniotic fluid.The management of chorioamnionitis mainly includes antibiotic therapy and delivery.Women with previable preterm premature rupture of membranes should be offered realistic counseling from a multidisciplinary approach.The separation of the mother and the fetus to preserve the life of the mother should prioritize delivery methods that result in a living fetus if possible,with appropriate neonatal resuscitation available. 展开更多
关键词 CHORIOAMNIONITIS Intraamniotic infection Maternal infection Fetal infection Cervical insufficiency ORGANISMS
原文传递
Puerperal Sepsis Caused by Clostridium Innocuum in a Patient with Placenta Accreta and Literature Review 被引量:1
6
作者 Liu Ping fan shang-rong +5 位作者 Liu Xiao-Ping Zhang Di-Rong Li Yun Wei Nan Zeng Li-Ping Peng Ji-Ying 《Maternal-Fetal Medicine》 2020年第3期181-188,共8页
To editor:Clostridium innocuum is a gram-positive spore forming bacillus that normally exists in the oral cavity and gastrointestinal tract.Although it is a rare pathogen for humans,C.innocuum can cause sepsis,especia... To editor:Clostridium innocuum is a gram-positive spore forming bacillus that normally exists in the oral cavity and gastrointestinal tract.Although it is a rare pathogen for humans,C.innocuum can cause sepsis,especially in patients with immunodeficiency,such as those presenting with acquired immunodeficiency syndrome,leukemia,tumors or organ transplants.Since C.innocuum is resistant to several common antibiotics(including vancomycin),it can lead to serious infection.1–5 We report a case of puerperal sepsis caused by C.innocuum in a patient with placenta accreta.The clinical characteristics of C.innocuum infection,as well as its antibiotic susceptibility,were reviewed.A treatment strategy for this rare infection was proposed.This is the first report of Puerperal sepsis caused by C.innocuum in English literature. 展开更多
关键词 SEPSIS Clostridium innocuum Puerperal Disorders Placenta accreta
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部